Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (171-180 of 309) with videos related to

Pageof 31
Sort By:
Journal of the International AIDS Society|October 24, 2018
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg ConsensusHezhao Ji, Eric Enns, Chanson J Brumme, et al.
Frontiers in Cellular and Infection Microbiology|March 13, 2023
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysisJose F Varona, Pedro Landete, Roger Paredes, et al.
AIDS Research and Human Retroviruses|January 10, 2020
A Summary of the Fourth Annual Virology Education HIV Microbiome WorkshopBrett Williams, Mimi Ghosh, Charles Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2008
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infectionJudith Dalmau, Maria Carmen Puertas, Marta Azuara, et al.
Nature Medicine|March 16, 2010
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsMaria J Buzón, Marta Massanella, Josep M Llibre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 22, 2022
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyondDaniel Simões, Soudeh Ehsani, Maja Stanojevic, et al.
Antiviral Therapy|January 18, 2005
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch StudyEugenia Negredo, Roger Paredes, Joaquim Peraire, et al.
Plos One|December 20, 2018
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variantCarolina Beltran-Pavez, Carolina B Ferreira, Alberto Merino-Mansilla, et al.
Open Forum Infectious Diseases|September 22, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART ProgramLucia Bailón, Yovaninna Alarcón-Soto, Angel Rivero, et al.
Open Forum Infectious Diseases|November 29, 2023
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral ClassesJosé R Santos, Pere Domingo, Joaquín Portilla, et al.
Pageof 31

Showing results (171-180 of 309) with videos related to

Sort By:
Pageof 31
Journal of the International AIDS Society|October 24, 2018
Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg ConsensusHezhao Ji, Eric Enns, Chanson J Brumme, et al.
Frontiers in Cellular and Infection Microbiology|March 13, 2023
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysisJose F Varona, Pedro Landete, Roger Paredes, et al.
AIDS Research and Human Retroviruses|January 10, 2020
A Summary of the Fourth Annual Virology Education HIV Microbiome WorkshopBrett Williams, Mimi Ghosh, Charles Boucher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2008
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infectionJudith Dalmau, Maria Carmen Puertas, Marta Azuara, et al.
Nature Medicine|March 16, 2010
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsMaria J Buzón, Marta Massanella, Josep M Llibre, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 22, 2022
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyondDaniel Simões, Soudeh Ehsani, Maja Stanojevic, et al.
Antiviral Therapy|January 18, 2005
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch StudyEugenia Negredo, Roger Paredes, Joaquim Peraire, et al.
Plos One|December 20, 2018
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variantCarolina Beltran-Pavez, Carolina B Ferreira, Alberto Merino-Mansilla, et al.
Open Forum Infectious Diseases|September 22, 2025
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART ProgramLucia Bailón, Yovaninna Alarcón-Soto, Angel Rivero, et al.
Open Forum Infectious Diseases|November 29, 2023
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral ClassesJosé R Santos, Pere Domingo, Joaquín Portilla, et al.
Pageof 31